230 related articles for article (PubMed ID: 2924321)
21. Histogenesis and differentiation potential of central neurocytomas.
von Deimling A; Kleihues P; Saremaslani P; Yasargil MG; Spoerri O; Südhof TC; Wiestler OD
Lab Invest; 1991 Apr; 64(4):585-91. PubMed ID: 1901927
[TBL] [Abstract][Full Text] [Related]
22. Expression of class I histocompatibility antigens in neuroectodermal tumors is independent of the expression of a transfected neuroblastoma myc gene.
Feltner DE; Cooper M; Weber J; Israel MA; Thiele CJ
J Immunol; 1989 Dec; 143(12):4292-9. PubMed ID: 2687378
[TBL] [Abstract][Full Text] [Related]
23. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction.
Gilbert J; Norris MD; Haber M; Kavallaris M; Marshall GM; Stewart BW
Mol Cell Probes; 1993 Jun; 7(3):227-34. PubMed ID: 8366868
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Myc targets in c-myc and N-myc induced human tumors.
Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
[TBL] [Abstract][Full Text] [Related]
25. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
26. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
27. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
[TBL] [Abstract][Full Text] [Related]
28. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
Tonini GP; Verdona G; Garaventa A; Cornaglia-Ferraris P
Anticancer Res; 1987; 7(4B):729-32. PubMed ID: 3314672
[TBL] [Abstract][Full Text] [Related]
29. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
Grandinetti KB; Spengler BA; Biedler JL; Ross RA
Oncogene; 2006 Feb; 25(5):706-12. PubMed ID: 16278682
[TBL] [Abstract][Full Text] [Related]
30. Amplification of N-myc in a rhabdomyosarcoma.
Mitani K; Kurosawa H; Suzuki A; Hayashi Y; Hanada R; Yamamoto K; Komatsu A; Kobayashi N; Nakagome Y; Yamada M
Jpn J Cancer Res; 1986 Nov; 77(11):1062-5. PubMed ID: 2432051
[TBL] [Abstract][Full Text] [Related]
31. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
[TBL] [Abstract][Full Text] [Related]
32. Gene aberrations in childhood brain tumors.
Kucerová H; Stejskalová E; Vícha A; Tichý M; Chánová M; Sumerauer D; Koutechký J; Eckschlager T
Folia Biol (Praha); 2000; 46(5):187-90. PubMed ID: 11055797
[TBL] [Abstract][Full Text] [Related]
33. [Oncogene amplification in human neuroblastomas].
Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
[TBL] [Abstract][Full Text] [Related]
34. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
Sejersen T; Björklund H; Sümegi J; Ringertz NR
J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
[TBL] [Abstract][Full Text] [Related]
35. Primitive neuroectodermal tumors (PNETs) of the CNS and PNS that express functional nerve growth factor receptors (NGFR) but fail to differentiate in response to NGF.
Reddy UR; Pleasure S; Baker D; Lee VM; Ross AH; Pleasure D
Prog Clin Biol Res; 1991; 366():243-8. PubMed ID: 1648743
[No Abstract] [Full Text] [Related]
36. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
38. Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas.
Shiloh Y; Korf B; Kohl NE; Sakai K; Brodeur GM; Harris P; Kanda N; Seeger RC; Alt F; Latt SA
Cancer Res; 1986 Oct; 46(10):5297-301. PubMed ID: 3756879
[TBL] [Abstract][Full Text] [Related]
39. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
40. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
